The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
The Europe Dialysis Market would witness market growth of 4.9% CAGR during the forecast period (2018 – 2024). Dialysis is used in removing waste products such as urea and creatinine from the blood which is caused due to the inappropriate functioning of kidney. The process is useful for people suffering from chronic renal failures. The technique is mostly used in treating end-stage renal disease and during kidney transplantation. With the help of this process, blood is purified, excess fluids and toxins are removed, and electrolyte balance is restored in the blood. Dialysis is carried out in two ways namely, hemodialysis and peritoneal dialysis. In the hemodialysis method, the waste products such as urea are removed extra corporeally from the blood of the person. In the peritoneal dialysis method, the peritoneum in the abdomen is used for dialysis. Growing cases of end-stage renal diseases, rise in diabetic cases, surge in funding for the development of new products with advanced technology, and rapid growth in the cases of kidney failure contributed to the growth of the dialysis market. However, limited levels of awareness about kidney diseases, product recall, and inefficient reimbursement policies would limit the market growth during the forecast period.
Based on End user, the market is segmented into In-Center Dialysis and Home Dialysis. Based on Products and Services, the, market is segmented into Services, equipment, Consumables and Drugs. Based on Type, the market is segmented into Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fresenius Medical Care Ag & Co. Kgaa, Baxter International, Inc., Davita Inc., Nipro Corporation, B. Braun Avitum Ag, Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nxstage Medical, Inc., Cantel Medical Corporation (Medicators, Inc)., Asahi Kasei Corporation.